Maraviroc
From Wikipedia, the free encyclopedia
Maraviroc is an chemokine receptor antagonist drug developed by the drug company Pfizer that is designed to act against HIV by interfering with the interaction between HIV and CCR5. It was originally labelled as UK-427857 during development but was assigned the Maraviroc name as it entered trials. As of early 2007, it is currently undergoing clinical trials.
[edit] External links
- BBC News story: Drug 'stops HIV's entry to cells'
- Maraviroc data at aidsmap
- Maraviroc early access program
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
